Browsing eNauka
Browsing by Author Pelemis, Mijomir R
Showing results 1 to 11 of 11
| Issue Date | Title | Author(s) | Type | М-cat. |
|---|---|---|---|---|
| 2008 | A Case Report: Blackwater Fever as a Complication of Falciparum Malaria | Poluga, Jasmina L   ; Dakic, Zorica D; Simonovic, Jasmina; Stevanovic, Goran D ; Pelemis, Mijomir R; Pavlovic, Milorad D | Conference Paper | Mp. category will be shown later |
| 2004 | Antibiotic policies in Central Eastern Europe | Cizman, Milan; Beovic, B; Krcmery, V; Barsic, B; Tamm, E; Ludwig, E; Pelemis, Mijomir R; Karovski, K; Grzesiowski, P; Gardovska, D;
Volokha, A; Keuleyan, E; Stratchounski, L; Dumitru, C; Titov, LP; Usonis, V; Dvorak, P;
| Article | 22M22 |
| 2012 | Efficacy and Safety of Tenofovir DF (TDF) in Chronic Hepatitis B Virus Infected Patients with Documented Lamivudine Resistance (LAM-R) | Fung, SC; Kwan, Peter; Fabri, Milotka J; Horban, Andrzej; Pelemis, Mijomir R; Husa, P; Hann, Hie-Won; Flaherty, John F; Massetto, Benedetto; Dinh, Phillip;
Corsa, Amoreena C; Kitrinos, Kathryn M; McHutchison, John G; Gane, E;
| Conference Paper | Mp. category will be shown later |
| 2007 | Enterococcus species as a blood-culture isolate-antimicrobial sensitivity | Tosic, Tanja O; Stosovic, Branka; Jovanovic, Milica M; Lavadinovic, Lidija S; Pelemis, Mijomir R | Conference Paper | Mp. category will be shown later |
| 2015 | Long Term Efficacy and Safety of Tenofovir DF (TDF) in Chronic Hepatitis B Patients (CHB) with Documented Lamivudine Resistance (LAM-R): 5 Year Results From a Randomized, Controlled Trial | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 15) | Conference Paper | Mp. category will be shown later |
| 2012 | Non-Specific Biological Markers as a Screening Test for Diagnostic of Extrapulmonary Tuberculosis | Stevanovic, Goran D ; Pelemis, Mijomir R; Pelemis, Svetislav M; Pavlovic, Milorad D | Article | 23M23 |
| 2014 | Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 16) | Article | 21aM21a |
| 2011 | Reduced bone mineral density derived from dual X-ray absorptiometry assessments in lamivudine experienced patients with chronic hepatitis B (CHB) | Fung, SC; Fabri, Miklos; Heathcoate, EJ; Gurel, S; Kwan, WCP; Caruntu, FA; Husa, P; Mazur, W; Pelemis, Mijomir R; Gane, E;
Coombs, D; Hirsch, KR;
| Conference Paper | Mp. category will be shown later |
| 2011 | Reduced Bone Mineral Density Derived From Dual X-Ray Absorptiometry Assessments in Patients with Chronic Hepatitis B (CHB) | Fung, SC; Fabri, Miklos; Wong, F; Heathcoate, EJ; Gurel, S; Kwan, WCP; Caruntu, FA; Husa, P; Mazur, W; Pelemis, Mijomir R;
Gane, E; Coombs, D; Hirsch, KR;
| Conference Paper | Mp. category will be shown later |
| 2013 | Tenofovir Df (Tdf) Is Safe and Well Tolerated in Chronic Hepatitis B (Chb) Patients with Pre-Existing Mild Renal Impairment | Fung, S; Kwan, Peter; Horban, A; Pelemis, Mijomir R; Husa, P; Hann, HW; Flaherty, John F; Massetto, Benedetto; Dinh, Phillip; Custodio, J;
Subramanian, GM; Fabri, Milotka J; Gane, E;
| Conference Paper | Mp. category will be shown later |
| 2017 | Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 22) | Article | 21aM21a |